MorphBio

“These systems biology models covering metabolic and secretory pathways will eventually allow us to understand how everything functions together. We will be able to learn what governs the different protein production capabilities for protein production in cell lines and clones.”

http://www.genengnews.com/gen-articles/systems-biology-finally-cho-ready/5667/

Systems Biology Finally CHO-Ready | GEN Magazine Articles | GEN

What are the key challenges during the production of biosimilar?

http://www.genengnews.com/gen-articles/biosimilar-manufacturing-challenges/5625/

Biosimilar Manufacturing Challenges | GEN Magazine Articles | GEN

AstraZeneca has agreed to buy ZS Pharma, the US biotech company, for $2.7bn in cash.

http://www.bizjournals.com/sanfrancisco/blog/biotech/2015/11/astrazeneca-zs-buy-biotech-bay-area-2-billion-azn.html

AstraZeneca to buy Bay Area biotech ZS Pharma for $2.7 billion - San Francisco Business Times The deal includes a new drug candidate with potential sales projected at more than $1 billion.